2T Triple Screening (Immulite)

2T Triple Screening (Immulite)

2T Triple Screening (Immulite) is a prenatal blood screening test performed during the second trimester of pregnancy to assess the risk of certain chromosomal abnormalities and neural tube defects in the developing baby.

Test Includes

• Alpha Fetoprotein (AFP)
• Human Chorionic Gonadotropin (hCG)
• Unconjugated Estriol (uE3)

Recommended During

Usually performed between 15 to 20 weeks of pregnancy.

Screens For

• Down Syndrome (Trisomy 21)
• Edwards Syndrome (Trisomy 18)
• Open Neural Tube Defects (ONTD)

Why Choose Immulite Technology?

• High accuracy and reliability
• Advanced chemiluminescent technology
• Early risk assessment
• Trusted laboratory results

Sample Required

Blood Sample

Benefits

• Helps identify pregnancies at increased risk
• Supports timely medical guidance and follow-up testing
• Non-invasive and safe for both mother and baby

Note

This is a screening test, not a diagnostic test. Abnormal results may require further confirmatory testing as advised by your doctor.

#AdvancedBiocareLaboratories #PregnancyScreening #TripleScreening #Immulite #PrenatalCare #MaternalHealth #DownSyndromeScreening #EdwardsSyndrome #NeuralTubeDefects #DiagnosticLab #Dermafact #gynofact